Pharmaceutical Technology: Apr 20, 2015
By AbbVie
Abbvie Contract Manufacturing has extensive experience and capacity across a wide variety of organisms including streptomycetes, actinomycetes, yeast, fungal, E. coli, and bacillus. Our expertise also includes fermentation with genetically modified organisms. AbbVie also is a multi-product approval facility and can manufacture products for a wide variety of industries including pharmaceutical, agricultural food, nutriceutical, enzymes and chemical.
Pharmaceutical Technology: Apr 16, 2015
This paper will discuss the use of isolators for the production of antibody drug conjugates providing operator protection during API preparation and providing product protection during final filling.
BioPharm International: Mar 31, 2015
Making the switch from batch to continuous manufacturing requires a thorough understanding of the process.
BioPharm International: Mar 31, 2015
The author explores various biocontainers—both old and new—in the single-use space.
Mar 29, 2015
By BioPharm International Editors
A consensus-based standard issued by NSF International incorporates regulatory and industry requirements into a single standard for the manufacturing and distribution of pharmaceutical excipients.
Mar 25, 2015
FDA has approved another indication for Eylea, a treatment for diabetic retinopathy in patients with diabetic macular edema.
BioPharm International: Mar 17, 2015
By BioPharm International Editors
WuXi's new US facility will manufacture CAR T-cell therapies and other cancer immunotherapies.
BioPharm International: Mar 03, 2015
By BioPharm International Editors
The upgrades will offer the opportunity for higher product yields and higher purity levels.
BioPharm International: Mar 01, 2015
Is there enough talent to go around?
Feb 23, 2015
By BioPharm International Editors
Leased facilities in California will expand Kite Pharma's capacity for T-cell therapies.